Neoadjuvant Therapy for Extrahepatic Biliary Tract Cancer: A Propensity Score-Matched Survival Analysis
<b>Background:</b> Although surgery is the mainstay of curative-intent treatment for extrahepatic biliary tract cancer (EBTC), recurrence following surgery can be high and prognosis poor. The impact of neoadjuvant therapy (NAT) relative to upfront surgery (US) among patients with EBTC re...
Main Authors: | Junya Toyoda, Kota Sahara, Tomoaki Takahashi, Kentaro Miyake, Yasuhiro Yabushita, Yu Sawada, Yuki Homma, Ryusei Matsuyama, Itaru Endo, Timothy M. Pawlik |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/12/7/2654 |
Similar Items
-
Immunotherapy and Targeted Therapy for Advanced Biliary Tract Cancer: Adding New Flavors to the Pizza
by: Marcello Moro Queiroz, et al.
Published: (2023-03-01) -
Molecular Features and Targeted Therapies in Extrahepatic Cholangiocarcinoma: Promises and Failures
by: Alessandro Rizzo, et al.
Published: (2020-11-01) -
The epidemiological trends of biliary tract cancers in the United States of America
by: Yong Jiang, et al.
Published: (2022-12-01) -
Approach to Biliary Malignancies
by: Louise Lee, et al.
Published: (2023-09-01) -
Novel insights into the intraepithelial spread of extrahepatic cholangiocarcinoma: clinicopathological study of 382 cases on extrahepatic cholangiocarcinoma
by: Daisuke Nagashima, et al.
Published: (2023-08-01)